The Ellison Institute of Technology (EIT) tackles humanity's greatest challenges by turning science and technology into impactful global solutions. Focused on areas like health, food security, sustainable agriculture, climate change, clean energy, and robotics in an era of artificial intelligence. EIT blends groundbreaking research with practical applications to deliver lasting results.
A cornerstone of EIT mission is its upcoming 300,000-square-foot research facility at the Oxford Science Park, set to open in 2027. This cutting-edge campus will feature advanced labs, an oncology and preventative care clinic, and collaborative spaces to strengthen its partnership with the University of Oxford. It will also host the Ellison Scholars, driving innovation for societal benefit.
The Generative Biology Institute (GBI) at the Ellison Institute of Technology (EIT) aims to overcome two major challenges in making biology engineerable: 1) the ability to precisely synthesize entire genomes, and 2) understanding which DNA sequences will create biological systems that perform desired functions. Solving these challenges will unlock the potential of biology for transformative solutions in health, sustainability, agriculture, and more. GBI will house 30 groups and over 300 researchers, supported by cutting-edge facilities and sustained funding to address global challenges and advance biology engineering.
EIT fosters a culture of collaboration, innovation, and resilience, valuing diverse expertise to drive sustainable solutions to humanity's enduring challenges.
Wellcome SynHG
Professor Chin is the lead Principal Investigator on the Wellcome Synthetic Human Genome (SynHG) project, for which research will be conducted at GBI in Oxford. The aim of the five-year multi-centre project (supported by £10m of funding) is to develop the foundational and scalable tools, technology and methods needed to synthesise large sections of human genomes/chromosomes. Through programmable synthesis of genetic material the aim is to unlock a deeper understanding of life, leading to potential acceleration of the development of safe, targeted, cell-based therapies, and opening entire new fields of research in human health. The project aims to achieve reliable genome design and synthesis - engineering cells to have specific functions - which will be a major milestone in modern biology. A dedicated social science program will support the research.
Job Summary:
EIT is seeking a highly motivatedPostdoctoral Researcher to join the Wellcome SynHG team based at GBI. The successful candidate will contribute to the research aims of the grant, working collaboratively and independently to design and conduct experiments, develop new techniques and approaches, and drive forward the scientific agenda. The Postdoctoral Researcher will play a key role in supporting lab development, and contributing to publications, reports, and presentations.
Key Responsibilities:
Essential & Desirable Knowledge, Skills and Experience:
We offer the following salary and benefits:
Why work for EIT:
At the Ellison Institute, we believe a collaborative, inclusive team is key to our success. We are building a supportive environment where creative risks are encouraged, and everyone feels heard. Valuing emotional intelligence, empathy, respect, and resilience, we encourage people to be curious and to have a shared commitment to excellence. Join us and make an impact!
Terms of Appointment: